Champions Oncology Return on Tangible Equity 2010-2025 | CSBR

Current and historical return on tangible equity values for Champions Oncology (CSBR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Champions Oncology Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-04-30 $0.00B $0.00B 228.57%
2025-01-31 $0.01B $0.01B 1200.00%
2024-10-31 $0.00B $0.00B 80.00%
2024-07-31 $0.00B $0.00B 320.00%
2024-04-30 $-0.01B $0.00B 1600.00%
2024-01-31 $-0.01B $0.00B -1100.00%
2023-10-31 $-0.01B $0.00B -307.69%
2023-07-31 $-0.01B $0.00B -145.45%
2023-04-30 $-0.01B $0.00B -68.97%
2023-01-31 $0.00B $0.01B -23.53%
2022-10-31 $0.00B $0.01B 11.11%
2022-07-31 $0.00B $0.01B 11.43%
2022-04-30 $0.00B $0.01B 12.12%
2022-01-31 $0.00B $0.01B 0.00%
2021-10-31 $0.00B $0.01B 0.00%
2021-07-31 $0.00B $0.01B 0.00%
2021-04-30 $0.00B $0.01B 0.00%
2021-01-31 $0.00B $0.01B -16.00%
2020-10-31 $0.00B $0.01B -40.00%
2020-07-31 $0.00B $0.01B -57.14%
2020-04-30 $0.00B $0.01B -120.00%
2020-01-31 $0.00B $0.00B -57.14%
2019-10-31 $0.00B $0.00B -66.67%
2019-07-31 $0.00B $0.00B -66.67%
2019-04-30 $0.00B $0.00B 0.00%
2019-01-31 $0.00B $0.00B -200.00%
2018-10-31 $0.00B $0.00B 0.00%
2018-07-31 $0.00B $0.00B 400.00%
2018-04-30 $0.00B $0.00B 800.00%
2018-01-31 $0.00B $0.00B 0.00%
2017-10-31 $0.00B $0.00B -1600.00%
2017-07-31 $-0.01B $0.00B -500.00%
2017-04-30 $-0.01B $0.00B -400.00%
2017-01-31 $-0.01B $0.00B -457.14%
2016-10-31 $-0.01B $0.00B -450.00%
2016-07-31 $-0.01B $0.00B -550.00%
2016-04-30 $-0.01B $0.00B -440.00%
2016-01-31 $-0.01B $0.00B -282.35%
2015-10-31 $-0.01B $0.00B -520.00%
2015-07-31 $-0.01B $0.01B -1300.00%
2015-04-30 $-0.01B $0.01B 5600.00%
2015-01-31 $-0.01B $-0.01B 960.00%
2014-10-31 $-0.01B $0.00B -1000.00%
2014-07-31 $-0.01B $0.00B 600.00%
2014-04-30 $-0.01B $0.00B 155.56%
2014-01-31 $-0.01B $0.00B 90.32%
2013-10-31 $-0.01B $-0.01B 65.12%
2013-07-31 $-0.01B $-0.01B 73.68%
2013-04-30 $-0.01B $-0.01B 72.73%
2013-01-31 $-0.01B $-0.01B 96.55%
2012-10-31 $-0.01B $-0.01B 128.00%
2012-07-31 $-0.01B $-0.01B 160.00%
2012-04-30 $-0.01B $-0.01B 240.00%
2012-01-31 $-0.01B $0.00B 360.00%
2011-10-31 $-0.01B $0.00B 700.00%
2011-07-31 $-0.01B $0.00B 0.00%
2011-04-30 $0.00B $0.00B -533.33%
2011-01-31 $0.00B $0.00B -160.00%
2010-10-31 $0.00B $0.00B -300.00%
2010-07-31 $0.00B $0.00B -533.33%
2010-04-30 $0.00B $0.00B -800.00%
2010-01-31 $0.00B $0.00B -800.00%
2009-10-31 $0.00B $0.00B -533.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.092B $0.057B
Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.478B 30.57
Zoetis (ZTS) United States $68.037B 25.39
Daiichi Sankyo, - (DSNKY) Japan $46.885B 24.03
Takeda Pharmaceutical (TAK) Japan $46.647B 9.28
BeOne Medicines - (ONC) Cayman Islands $32.492B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.501B 0.00
Summit Therapeutics (SMMT) United States $20.475B 0.00
Merck (MKKGY) Germany $17.325B 12.69
Shionogi (SGIOY) Japan $14.589B 14.62
United Therapeutics (UTHR) United States $13.821B 12.23
Neurocrine Biosciences (NBIX) United States $13.028B 44.62
Orion OYJ (ORINY) Finland $11.714B 28.23
IPSEN (IPSEY) France $11.064B 0.00
Stevanato Group S.p.A (STVN) Italy $8.464B 51.76
Corcept Therapeutics (CORT) United States $7.168B 58.27
Grifols, S.A (GRFS) Spain $6.834B 0.00
Ionis Pharmaceuticals (IONS) United States $6.709B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.643B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.204B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.436B 0.00
Hypermarcas (HYPMY) Brazil $3.085B 20.29
Crinetics Pharmaceuticals (CRNX) United States $2.847B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.626B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.564B 8.98
Procaps Group, S.A (PROCF) Luxembourg $2.534B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.507B 13.56
Centessa Pharmaceuticals (CNTA) United Kingdom $2.067B 0.00
Ocular Therapeutix (OCUL) United States $1.899B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.789B 0.00
ARS Pharmaceuticals (SPRY) United States $1.760B 0.00
Endo (NDOI) United States $1.755B 0.00
Evotec AG (EVO) Germany $1.438B 0.00
Harrow (HROW) United States $1.366B 0.00
Guardian Pharmacy Services (GRDN) United States $1.283B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.225B 24.51
Avadel Pharmaceuticals (AVDL) Ireland $1.088B 0.00
Enliven Therapeutics (ELVN) United States $1.077B 0.00
Dyne Therapeutics (DYN) United States $1.050B 0.00
Ardelyx (ARDX) United States $1.043B 0.00
Collegium Pharmaceutical (COLL) United States $1.032B 5.57
Akebia Therapeutics (AKBA) United States $1.009B 0.00
Verve Therapeutics (VERV) United States $0.992B 0.00
ProKidney (PROK) United States $0.954B 0.00
Xeris Biopharma Holdings (XERS) United States $0.809B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
KalVista Pharmaceuticals (KALV) United States $0.779B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.740B 0.00
Xencor (XNCR) United States $0.658B 0.00
Zevra Therapeutics (ZVRA) United States $0.638B 0.00
Relay Therapeutics (RLAY) United States $0.631B 0.00
Organogenesis (ORGO) United States $0.603B 0.00
USANA Health Sciences (USNA) United States $0.598B 12.02
Elite Pharmaceuticals (ELTP) United States $0.580B 0.00
Theravance Biopharma (TBPH) United States $0.557B 0.00
Oruka Therapeutics (ORKA) United States $0.533B 0.00
Bioventus (BVS) United States $0.526B 13.33
Siga Technologies (SIGA) United States $0.504B 10.54
Tourmaline Bio (TRML) United States $0.482B 0.00
Savara (SVRA) United States $0.441B 0.00
Aquestive Therapeutics (AQST) United States $0.417B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.365B 9.87
AleAnna (ANNA) United States $0.357B 0.00
Altimmune (ALT) United States $0.333B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.329B 0.00
Aldeyra Therapeutics (ALDX) United States $0.326B 0.00
Nanobiotix S.A (NBTX) France $0.306B 0.00
Nektar Therapeutics (NKTR) United States $0.305B 0.00
Esperion Therapeutics (ESPR) United States $0.295B 0.00
Heron Therapeutics (HRTX) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.20
OmniAb (OABI) United States $0.259B 0.00
Larimar Therapeutics (LRMR) United States $0.240B 0.00
MediWound (MDWD) Israel $0.225B 0.00
Liminatus Pharma (LIMN) United States $0.220B 0.00
4D Molecular Therapeutics (FDMT) United States $0.214B 0.00
China SXT Pharmaceuticals (SXTC) China $0.188B 0.00
Galectin Therapeutics (GALT) United States $0.186B 0.00
Aclaris Therapeutics (ACRS) United States $0.182B 0.00
Journey Medical (DERM) United States $0.179B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Avita Medical (RCEL) United States $0.158B 0.00
Lyell Immunopharma (LYEL) United States $0.154B 0.00
Korro Bio (KRRO) United States $0.149B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.133B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Lexeo Therapeutics (LXEO) United States $0.122B 0.00
Cassava Sciences (SAVA) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Nutriband (NTRB) United States $0.098B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
Metagenomi (MGX) United States $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.094B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Pyxis Oncology (PYXS) United States $0.083B 0.00
Inotiv (NOTV) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Surrozen (SRZN) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.073B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Avalo Therapeutics (AVTX) United States $0.072B 0.00
Wellgistics Health (WGRX) United States $0.068B 0.00
Telomir Pharmaceuticals (TELO) United States $0.068B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Klotho Neurosciences (KLTO) United States $0.058B 0.00
Century Therapeutics (IPSC) United States $0.057B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Jupiter Neurosciences (JUNS) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 37.33
Incannex Healthcare (IXHL) Australia $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.036B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
DURECT (DRRX) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 2.65
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.83
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00